Zinc Inhibition of Renin and the Protease from Human Immunodeficiency Virus Type 1

Zhong Yin Zhang, Ilene M. Reardon, John O. Hui, Kathy L. O’Connell, Roger A. Poorman, Alfredo G. Tomasselli, Robert L. Heinrikson

Research output: Contribution to journalArticlepeer-review

54 Scopus citations


We report here for the first time that Zn2+ is an effective inhibitor of renin and the protease from HIV-1, two aspartyl proteinases of considerable physiological importance. Inhibition of renin is noncompetitive and is accompanied by binding of 1 mol of Zn2+/mol of enzyme. Depending on the substrate, inhibition of the HIV protease by Zn2+ can be either competitive or noncompetitive, but in neither case is loss of activity due to disruption of the protease dimer. Inhibition of both enzymes is first order with respect to Zn2+ and is rapidly reversed by addition of EDTA. Ki values are strongly pH dependent and optimal in the range of 20 μM at or above pH 7. All of the data in hand suggest that the inhibitory effect of Zn2+ is a consequence of its binding at, or near, the active-site carboxyl groups of these aspartyl proteinases. This inhibition of the viral enzyme may help to explain some of the beneficial effects seen in AIDS patients who have received Zn2+ therapy.

Original languageEnglish (US)
Pages (from-to)8717-8721
Number of pages5
Issue number36
StatePublished - Sep 1 1991
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry

Fingerprint Dive into the research topics of 'Zinc Inhibition of Renin and the Protease from Human Immunodeficiency Virus Type 1'. Together they form a unique fingerprint.

Cite this